Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrunner Inv.tst Regulatory News (BUT)

Share Price Information for Brunner Inv.tst (BUT)

Share Price is delayed by 15 minutes
Get Live Data
1,446.00    0.00 (0.00%)
Bid:
1,450.00
Ask:
1,458.00
Spread: 8.00 (0.552%)
Market Cap: £622.95m
BUT Live PriceLast checked at - London Stock Exchange

Intraday Brunner Inv.tst Share Chart

Edison issues review on The Brunner IT

17 May 2023 07:00

RNS Number : 5738Z
Brunner Investment Trust PLC
17 May 2023
 

London, UK, 17 May 2023

 

Edison issues review on The Brunner Investment Trust (BUT)

The Brunner Investment Trust (BUT) is led by a very strong team at Allianz Global Investors (AllianzGI). Its two co-managers, Christian Schneider (deputy CIO Global Growth) and Julian Bishop (global equity specialist), are supported by deputy managers Marcus Morris-Eyton (European equity specialist) and Simon Gergel (CIO UK Equities). The trust has notably outperformed its benchmark over each of the last four financial years despite significant market rallies and falls and periods of growth and value stock leadership. BUT's NAV total return is above the average of the 13 funds in the AIC Global sector over the last one, three and five years (ranking second over three years). The trust has delivered 51 consecutive years of higher dividends plus capital growth for investors.

 

The latest 11.0% share price discount to NAV could provide an interesting opportunity for new and existing investors, as it essentially implies an 11% discount on the price of some of the best companies in the world and is equivalent to around 18 years of ongoing charges.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGCGDUGDBDGXL
Date   Source Headline
9th Jun 20261:41 pmRNSNet Asset Value(s)
8th Jun 20265:21 pmRNSPortfolio Update
8th Jun 20262:55 pmRNSNet Asset Value(s)
8th Jun 202611:12 amRNSTop 10 Holdings & Geographical Distribution
5th Jun 20262:44 pmRNSNet Asset Value(s)
4th Jun 20264:30 pmRNSDividend Declaration
4th Jun 20262:16 pmRNSNet Asset Value(s)
3rd Jun 20262:02 pmRNSNet Asset Value(s)
2nd Jun 20262:01 pmRNSNet Asset Value(s)
1st Jun 20261:37 pmRNSNet Asset Value(s)
1st Jun 202612:52 pmRNSTotal Voting Rights
29th May 20261:48 pmRNSNet Asset Value(s)
28th May 20261:57 pmRNSNet Asset Value(s)
27th May 20264:47 pmRNSBlocklisting return
27th May 20262:18 pmRNSNet Asset Value(s)
26th May 20262:05 pmRNSNet Asset Value(s)
22nd May 20261:29 pmRNSNet Asset Value(s)
21st May 20261:31 pmRNSNet Asset Value(s)
20th May 20265:13 pmRNSTransaction in Own Shares
20th May 20261:41 pmRNSNet Asset Value(s)
19th May 20261:35 pmRNSNet Asset Value(s)
18th May 20261:55 pmRNSNet Asset Value(s)
15th May 20262:22 pmRNSNet Asset Value(s)
14th May 20261:26 pmRNSNet Asset Value(s)
13th May 20261:54 pmRNSNet Asset Value(s)
12th May 20261:50 pmRNSNet Asset Value(s)
11th May 20262:02 pmRNSNet Asset Value(s)
8th May 20261:55 pmRNSNet Asset Value(s)
7th May 20262:07 pmRNSNet Asset Value(s)
7th May 202611:12 amRNSTop 10 Holdings & Geographical Distribution
6th May 20261:27 pmRNSNet Asset Value(s)
5th May 20264:51 pmRNSTotal Voting Rights
5th May 20261:10 pmRNSNet Asset Value(s)
1st May 20262:00 pmRNSNet Asset Value(s)
30th Apr 20262:44 pmRNSNet Asset Value(s)
29th Apr 20262:13 pmRNSNet Asset Value(s)
28th Apr 20261:37 pmRNSNet Asset Value(s)
27th Apr 20261:25 pmRNSNet Asset Value(s)
24th Apr 20263:18 pmRNSNet Asset Value(s)
23rd Apr 20263:10 pmRNSNet Asset Value(s)
22nd Apr 20261:56 pmRNSNet Asset Value(s)
21st Apr 20261:13 pmRNSNet Asset Value(s)
20th Apr 20262:51 pmRNSNet Asset Value(s)
17th Apr 20262:10 pmRNSNet Asset Value(s)
16th Apr 20264:05 pmRNSNet Asset Value(s)
16th Apr 20263:55 pmRNSTop 10 Holdings & Geographical Distribution
15th Apr 20263:07 pmRNSTransaction in Own Shares - Replacement
15th Apr 20262:34 pmRNSNet Asset Value(s)
14th Apr 20265:13 pmRNSTransaction in Own Shares
14th Apr 20262:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.